Alliancebernstein L.P. Crinetics Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 93,020 shares of CRNX stock, worth $4.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,020

Previous 110,674 15.95%

Holding current value

$4.05 Million

Previous $3.71 Million 27.94%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$25.56 - $33.76 $451,236 - $595,999	-17,654 Reduced 15.95%	93,020 $2.68 Million
Q1 2025 May 15, 2025	BUY	$32.3 - $53.15 $289,214 - $475,905	8,954 Added 8.8%	110,674 $3.71 Million
Q4 2024 Feb 12, 2025	BUY	$50.66 - $60.69 $465,565 - $557,741	9,190 Added 9.93%	101,720 $5.2 Million
Q2 2024 Aug 14, 2024	BUY	$42.12 - $51.91 $1.06 Million - $1.31 Million	25,260 Added 37.55%	92,530 $4.14 Million
Q4 2023 Feb 14, 2024	BUY	$25.62 - $37.07 $157,050 - $227,239	6,130 Added 10.03%	67,270 $2.39 Million
Q3 2023 Nov 14, 2023	BUY	$15.97 - $30.59 $158,741 - $304,064	9,940 Added 19.41%	61,140 $1.82 Million
Q2 2022 Aug 15, 2022	BUY	$16.49 - $27.64 $356,183 - $597,024	21,600 Added 72.97%	51,200 $955,000
Q1 2022 May 13, 2022	BUY	$17.15 - $28.31 $1,714 - $2,831	100 Added 0.34%	29,600 $650,000
Q2 2021 Jul 30, 2021	BUY	$15.9 - $21.15 $42,930 - $57,104	2,700 Added 10.07%	29,500 $556,000
Q1 2021 May 06, 2021	SELL	$13.3 - $17.55 $14,630 - $19,305	-1,100 Reduced 3.94%	26,800 $410,000
Q4 2020 Feb 08, 2021	BUY	$12.08 - $17.46 $24,160 - $34,920	2,000 Added 7.72%	27,900 $394,000
Q2 2020 Aug 13, 2020	BUY	$13.04 - $23.23 $144,744 - $257,853	11,100 Added 75.0%	25,900 $454,000
Q1 2020 May 14, 2020	BUY	$11.52 - $26.46 $34,560 - $79,380	3,000 Added 25.42%	14,800 $218,000
Q4 2019 Feb 18, 2020	BUY	$15.24 - $25.09 $9,144 - $15,054	600 Added 5.36%	11,800 $296,000
Q3 2019 Nov 14, 2019	BUY	$14.91 - $25.01 $32,802 - $55,022	2,200 Added 24.44%	11,200 $168,000
Q2 2019 Aug 14, 2019	BUY	$21.48 - $27.71 $193,320 - $249,390	9,000 New	9,000 $225,000

Others Institutions Holding CRNX

# of Institutions

238

Shares Held

90.3M

Call Options Held

59.7K

Put Options Held

14.8K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.34B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Crinetics Pharmaceuticals, Inc. Transaction History